
    
      The purpose of this research study is to determine the safety and efficacy of a reduced
      intensity conditioning regimen during a double umbilical cord blood unit transplant with one
      of the cord blood units modulated with ProHema.

      -As part of this research study cord units will be modulated in the laboratory with ProHema
      before it is given to the participant. Two different treatment groups will be tested. Group
      1: will have the second cord blood unit modulated with ProHema; Group 2: will have the first
      cord blood unit modulated with ProHema.
    
  